Clinical trial simulations– an essential tool in drug development

Main Page Image

Publication date:
14/08/2014

Publication
ref:

The clinical development of investigational drugs is a complex and expensive process. The costs can be affectedby decisions that are taken as clinical trials progress from one stage to the next (eg dose selection studies andtransitions from Phase 2 to Phase 3 clinical trials).

Clinical trial simulations are being increasingly viewed as anintegral part of clinical development programmes and can be used to improve the understanding and decisionmaking at every stage of drug development.

In this article we provide an example led overview illustrating the impact that simulations can have along the drug development timeline.

Get in touch

I am happy for ABPI to keep my details on file and to send me details of future ABPI work and services. ABPI will not sell your data to any third party or send you any information about products or services that ABPI has no direct connection with.